- Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
-
Yoo J, Cho H, Lee DH, Cho EJ, Joo I, Jeon SK
- KMID: 2546389
- Clin Mol Hepatol.
- 2023 Oct;29(4):1029-1042.
- doi: 10.3350/cmh.2023.0190
Background/Aims: The prediction of clinical outcomes in patients with chronic hepatitis B (CHB) is paramount for effective management. This study aimed to evaluate the prognostic value of computed tomography (CT)... -
- CITED
-
- Close
- SHARE
-
- Close
- Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
-
Emiroglu HH
- KMID: 2543997
- Clin Mol Hepatol.
- 2023 Jul;29(3):812-812.
- doi: 10.3350/cmh.2023.0132
-
- CITED
-
- Close
- SHARE
-
- Close
- Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
-
Lin CL, Kao JH
- KMID: 2543983
- Clin Mol Hepatol.
- 2023 Jul;29(3):605-622.
- doi: 10.3350/cmh.2022.0342
Hepatitis B virus (HBV) is responsible for more than 50% of hepatocellular carcinoma (HCC) in HBV hyperendemic areas, such as the Asia-Pacific region. Several hepatitis B viral factors are involved... -
- CITED
-
- Close
- SHARE
-
- Close
- Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
-
Cho Y, Kim BH, Park JW
- KMID: 2541404
- Clin Mol Hepatol.
- 2023 Apr;29(2):252-262.
- doi: 10.3350/cmh.2023.0099
Hepatocellular carcinoma (HCC) is highly prevalent and the third most common cause of cancer-related death in Asia. In contrast to the West, the main etiology of HCC in many Asian... -
- CITED
-
- Close
- SHARE
-
- Close
- Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
-
Yoo JJ, Kim SG
- KMID: 2541440
- Clin Mol Hepatol.
- 2023 Apr;29(2):513-515.
- doi: 10.3350/cmh.2023.0044
-
- CITED
-
- Close
- SHARE
-
- Close
- Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”
-
Chu CM, Liaw YF
- KMID: 2541439
- Clin Mol Hepatol.
- 2023 Apr;29(2):510-512.
- doi: 10.3350/cmh.2023.0018
-
- CITED
-
- Close
- SHARE
-
- Close
- The role of different viral biomarkers on the management of chronic hepatitis B
-
Mak LY, Hui RWH, Fung J, Seto WK, Yuen MF
- KMID: 2541405
- Clin Mol Hepatol.
- 2023 Apr;29(2):263-276.
- doi: 10.3350/cmh.2022.0448
Chronic hepatitis B infection is a major public health challenge. With the advancement in technology, various components of the viral cycle can now be measured in the blood to assess... -
- CITED
-
- Close
- SHARE
-
- Close
- Telbivudine-Induced Myopathy: Clinical Features, Histopathological Characteristics, and Risk Factors
-
Lan MY, Lin HCL, Hu TH, Chen SFC, Chen CH, Chang YY, Chiu KW, Lin TK, Chen SS
- KMID: 2537184
- J Clin Neurol.
- 2023 Jan;19(1):52-59.
- doi: 10.3988/jcn.2023.19.1.52
Background and Purpose Oral nucleos(t)ide analogs (NAs) are the mainstay treatment for chronic hepatitis B (CHB). Myotoxicity is an important extrahepatic effect related to NA treatment. Telbivudine is the NA... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
-
Mak LY, Wong D, Kuchta A, Hilfiker M, Hamilton A, Chow N, Mao X, Seto WK, Yuen MF
- KMID: 2538211
- Clin Mol Hepatol.
- 2023 Jan;29(1):146-162.
- doi: 10.3350/cmh.2022.0172
Background/Aims: We investigated the dynamics of serum HBV pre-genomic RNA (pgRNA) and hepatitis B core-related antigen (HBcrAg) in patients receiving nucleos(t)ide analogues (NAs) and their predictability for favourable suppression of... -
- CITED
-
- Close
- SHARE
-
- Close
- COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
-
Cheung KS, Mok CH, Mao X, Zhang R, Hung IF, Seto WK, Yuen MF
- KMID: 2534353
- Clin Mol Hepatol.
- 2022 Oct;28(4):890-911.
- doi: 10.3350/cmh.2022.0087
Background/Aims: Data of coronavirus disease 2019 (COVID-19) vaccine immunogenicity among chronic liver disease (CLD) and liver transplant (LT) patients are conflicting. We performed meta-analysis to examine vaccine immunogenicity regarding etiology,... -
- CITED
-
- Close
- SHARE
-
- Close
- The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
-
Yu JH, Cho SG, Jin YJ, Lee JW
- KMID: 2531364
- Clin Mol Hepatol.
- 2022 Jul;28(3):351-361.
- doi: 10.3350/cmh.2021.0281
Chronic hepatitis B (CHB) seriously threatens human health. About 820,000 deaths annually are due to related complications such as hepatitis B and hepatocellular carcinoma (HCC). Recently, the use of oral... -
- CITED
-
- Close
- SHARE
-
- Close
- KASL clinical practice guidelines for management of chronic hepatitis B
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2528259
- Clin Mol Hepatol.
- 2022 Apr;28(2):276-331.
- doi: 10.3350/cmh.2022.0084
-
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis
-
Jeong J, Shin JW, Jung SW, Park EJ, Park NH
- KMID: 2528254
- Clin Mol Hepatol.
- 2022 Apr;28(2):254-264.
- doi: 10.3350/cmh.2021.0314
Background/Aims: Tenofovir alafenamide (TAF) has shown less favorable effect on lipids compared to tenofovir disoproxil fumarate (TDF) in clinical trials. However, data regarding these outcomes in patients with chronic hepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of superb microvascular imaging and shear wave elastography for assessing liver fibrosis in chronic hepatitis B
-
Tosun M, Uslu H
- KMID: 2527441
- Ultrasonography.
- 2022 Apr;41(2):394-402.
- doi: 10.14366/usg.21136
Purpose: The present study investigated the effectiveness and applicability of superb microvascular imaging (SMI) in determining the degree of liver fibrosis noninvasively in comparison with shear wave elastography (SWE). Methods: Ninety-eight... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Effect of Hepatitis B Virus on COVID-19 Infected Patients: A Nationwide Population-Based Study Using the Health Insurance Review & Assessment Service Database
-
Choe JW, Jung YK, Yim HJ, Seo GH
- KMID: 2525010
- J Korean Med Sci.
- 2022 Jan;37(4):e29.
- doi: 10.3346/jkms.2022.37.e29
Background: Several studies have recently suggested that liver disease and cirrhosis were risk factors for poor outcomes in patients with coronavirus disease 2019 (COVID-19) infections. However, no large data study has... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases
-
Tamaki N, Kurosaki M, Loomba R, Izumi N
- KMID: 2512730
- Ann Lab Med.
- 2021 Jan;41(1):16-24.
- doi: 10.3343/alm.2021.41.1.16
An accurate evaluation of liver fibrosis is clinically important in chronic liver diseases. Mac-2 binding protein glycosylation isomer (M2BPGi) is a novel serum marker for liver fibrosis. In this review,... -
- CITED
-
- Close
- SHARE
-
- Close
- Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
-
Mak LY, Ko KL, To WP, Wong DKH, Seto WK, Fung J, Yuen MF
- KMID: 2506442
- Gut Liver.
- 2020 Sep;14(5):665-668.
- doi: 10.5009/gnl19434
Serum hepatitis B core-related antigen (HBcrAg) was shown to predict the risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients undergoing treatment. We investigated the longitudinal profile of... -
- CITED
-
- Close
- SHARE
-
- Close
- Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?
-
Jang BK
- KMID: 2504505
- Clin Mol Hepatol.
- 2020 Jul;26(3):312-314.
- doi: 10.3350/cmh.2020.0099
-
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B vaccination and immunotherapies: an update
-
Stasi C, Silvestri , Voller F
- KMID: 2470832
- Clin Exp Vaccine Res.
- 2020 Jan;9(1):1-7.
- doi: 10.7774/cevr.2020.9.1.1
World Health Organization (WHO) estimates that 257 million people were living with chronic hepatitis B virus (HBV) infection. Highest HBV prevalence was found in the WHO Western Pacific Region (6.2%)... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Statin Use on Liver Cancer Mortality Considering Hypercholesterolemia and Obesity in Patients with Non-Cirrhotic Chronic Hepatitis B
-
Kim GA, Shim JJ, Lee JS, Kim BH, Kim JW, Oh CH, Oh CM, Oh IH, Park SY
- KMID: 2463800
- Yonsei Med J.
- 2019 Dec;60(12):1203-1208.
- doi: 10.3349/ymj.2019.60.12.1203
Little is known about the benefits of statin use on liver cancer mortality among patients with chronic hepatitis B (CHB) considering hypercholesterolemia and obesity. A nationwide retrospective cohort study was... -
- CITED
-
- Close
- SHARE
-
- Close
